For Queries or Clarification contact :

Kenya iTARA Data Summary (as of 2026-03-12)

Below is a summary of the iTARA Data and Plots which highlights the main data points of the study.

  • Recruiting sites 3 : Rhodes, Karen & Riruta

Total Number of Participants Screened in the Study.

screen_phc_ke n percent
Rhodes 889 53.9%
Karen 431 26.2%
Riruta 328 19.9%
Total 1648 100.0%

Participants Gender & Site Data

screen_phc_ke Female Male
Rhodes 41.8% (372) 58.2% (517)
Karen 54.8% (236) 45.2% (195)
Riruta 62.8% (206) 37.2% (122)
Total 49.4% (814) 50.6% (834)

The table below show the total number of participnats screened this week

screen_phc_ke n percent
Rhodes 22 46.8%
Karen 12 25.5%
Riruta 13 27.7%
Total 47 100.0%

Screening Eligibility

screen_eligible_conf Rhodes Karen Riruta Total
Yes 193 132 125 450
No 696 299 203 1198

The table below show the total number of participants screened, eligible and those not eligible this week

screen_eligible_conf Rhodes Karen Riruta Total
Yes 9 6 10 25
No 13 6 3 22

ELigible and Consented partcipants

screen_consent_yn Rhodes Karen Riruta Total
Yes 193 123 116 432
No 1 9 48 58
NA 695 299 164 1158

Removed all NAs from the data above

screened$screen_consent_yn n percent
Yes 432 88.2%
No 58 11.8%
Total 490 -

The table below show the total number of participnats consented to the study this week

screen_consent_yn Rhodes Karen Riruta Total
Yes 9 6 10 25
No 0 0 2 2
NA 13 6 1 20

Baseline Enrollment Summary Plots

  • Monthly Sites Participant Enrollment

Monthly Site Baseline total Numbers

enrol_phc_ke Jun 2025 Jul 2025 Aug 2025 Sept 2025 Oct 2025 Nov 2025 Dec 2025 Jan 2026 Feb 2026 Mar 2026 Total
Karen 27 25 9 11 10 8 3 4 14 12 123
Rhodes 14 38 19 21 17 12 12 12 29 19 193
Riruta 0 0 0 14 11 12 2 4 50 23 116
Total 41 63 28 46 38 32 17 20 93 54 432
  • Sites Participant Enrollment Against the Monthly Target
  • Monthly cumulative total participants enrollment.

Xpert Data and Summary

enrol_phc_ke Positive Negative Trace Indeterminate No sputum NA_
Rhodes 93 99 0 0 0 1
Karen 4 113 0 0 6 0
Riruta 17 98 0 0 1 0
Total 114 310 0 0 7 1
xpert_result n percent valid_percent
Positive 114 26% 26%
Negative 310 72% 72%
Trace 0 0% 0%
Indeterminate 0 0% 0%
No sputum 7 2% 2%
NA 1 0% -
Total 432 - -
Positive Negative Trace Indeterminate No sputum NA_
Rhodes
48.2% (93) 51.3% (99) 0.0% (0) 0.0% (0) 0.0% (0) 0.5% (1)
Karen
3.3% (4) 91.9% (113) 0.0% (0) 0.0% (0) 4.9% (6) 0.0% (0)
Riruta
14.7% (17) 84.5% (98) 0.0% (0) 0.0% (0) 0.9% (1) 0.0% (0)
Total
26.4% (114) 71.8% (310) 0.0% (0) 0.0% (0) 1.6% (7) 0.2% (1)

Xpert Summary and Plot of Results

Baseline Participants

enrol_phc_ke n percent
Rhodes 193 40.0%
Karen 123 30.0%
Riruta 116 30.0%
Total 432 100.0%

Weekly baseline Participants Number

enrol_phc_ke n percent
Rhodes 9 36.0%
Karen 6 24.0%
Riruta 10 40.0%
Total 25 100.0%

Cohort Participants

obs_phc_ke n percent
Rhodes 90 31.1%
Karen 103 35.6%
Riruta 96 33.2%
Total 289 100.0%

Weekly Cohort Participants

obs_phc_ke n percent
Rhodes 2 11.1%
Karen 6 33.3%
Riruta 10 55.6%
Total 18 100.0%

Site Cohort recruitment numbers over time

Monthly Site Cohort Enrollment bar plots

Monthly Site Cohort total Numbers

obs_phc_ke Jun 2025 Jul 2025 Aug 2025 Sept 2025 Oct 2025 Nov 2025 Dec 2025 Jan 2026 Feb 2026 Mar 2026 Total
Karen 12 24 10 6 11 7 3 4 14 12 103
Rhodes 6 19 7 11 13 2 3 8 15 6 90
Riruta 0 0 0 6 12 5 3 2 49 19 96
Total 18 43 17 23 36 14 9 14 78 37 289

Monthly Sites cohort enrollment against the target

Monthly Cummulative Site Cohort Enrolment Against the Target.

Number of participant who have had 26 week follow up visit done

obs_phc_ke n
Rhodes 24
Karen 35
Total 59

Weekly 26 week follow up Summary (as of 2026-03-12)

obs_phc_ke n
Rhodes 2
Karen 2
Total 4

Participants Exited from the Study, (as of 2026-03-12)

Total Number of exited participants with reasons

exit_reason n
Completed all follow up (26 week visit and MGIT result feedback) 24
Study withdrawal 7
Lost to follow up (missed visit procedures completed) 6
Notified of participant death 5
Other 22
No longer eligible (baseline Xpert positive) 102
No longer eligible (baseline MGIT positive) 7
Total 173

Number of exited participants with Other reasons

exit_reason exit_reason_detail n
Other Failed to attend study visit within stipulated timeline 1
Other LAM positive results 1
Other LAM positive results 1
Other Missed baselines cohort visit within study window 1
Other Out of window period 3
Other Outside the window period 1
Other Outside the window period 7
Other Outside window period 1
Other Outside window period 1
Other Participant could not attend the baseline cohort visit within the study window 1
Other Participant realised she was pregnant 1
Other Participant urine lam turned positive 1
Other Participant was not feeling well during the window period of cohort enrollment 1
Other Work related matters 1
Total - 22

Updated Cohort list after participants Exit

Exited cohort participants

exit_reason n percent
Completed all follow up (26 week visit and MGIT result feedback) 24 52.2%
Study withdrawal 1 2.2%
Lost to follow up (missed visit procedures completed) 6 13.0%
Notified of participant death 5 10.9%
Other 3 6.5%
No longer eligible (baseline Xpert positive) 0 0.0%
Not selected for cohort 0 0.0%
No longer eligible (baseline MGIT positive) 7 15.2%
Total 46 100.0%

Exited cohort participants with Other Reasons

exit_reason exit_reason_detail n
Other LAM positive results 1
Other LAM positive results 1
Other Participant urine lam turned positive 1
Total - 3

Remaining Cohort Participants After exited participants

obs_phc_ke n
Rhodes 79
Karen 70
Riruta 94
Total 243